Loading
Metanovas Biotech
Metanovas is a metabolic drug developer focused on combining artificial intelligence with life sciences, using deep learning.
Funding
Every round, secondary, debt facility or acquisition involving Metanovas Biotech that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log in